Stay updated on Recombinant Prourokinase for Acute Pulmonary Embolism Clinical Trial
Sign up to get notified when there's something new on the Recombinant Prourokinase for Acute Pulmonary Embolism Clinical Trial page.

Latest updates to the Recombinant Prourokinase for Acute Pulmonary Embolism Clinical Trial page
- ChecktodayChange DetectedNo additions or deletions were detected on the page. The content appears unchanged between the two screenshots.SummaryDifference0.4%

- Check8 days agoNo Change Detected
- Check29 days agoChange DetectedUpdated the page to v3.2.0 with a prominent notice about potential data/tansaction delays due to funding gaps and where to check operating status; previous v3.1.0 reference removed.SummaryDifference5%

- Check36 days agoChange DetectedUpdate: revision tag changed from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.1%

- Check51 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2 and the Back to Top element was removed; no other substantive changes to content, pricing, stock, or time slots.SummaryDifference0.3%

- Check58 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content or other important elements.SummaryDifference0.3%

- Check65 days agoChange DetectedThe web page has undergone significant updates, including the addition of new facility names and locations in Beijing and Tianjin, while removing several previous location references and medical topics.SummaryDifference6%

Stay in the know with updates to Recombinant Prourokinase for Acute Pulmonary Embolism Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Recombinant Prourokinase for Acute Pulmonary Embolism Clinical Trial page.